BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19695436)

  • 1. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.
    Marini P; Budach W; Niyazi M; Junginger D; Stickl S; Jendrossek V; Belka C
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):198-202. PubMed ID: 19695436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.
    Marini P; Denzinger S; Schiller D; Kauder S; Welz S; Humphreys R; Daniel PT; Jendrossek V; Budach W; Belka C
    Oncogene; 2006 Aug; 25(37):5145-54. PubMed ID: 16636678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
    Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.
    Marini P; Junginger D; Stickl S; Budach W; Niyazi M; Belka C
    Radiat Oncol; 2009 Oct; 4():49. PubMed ID: 19860913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
    Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
    Maddipatla S; Hernandez-Ilizaliturri FJ; Knight J; Czuczman MS
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4556-64. PubMed ID: 17671142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.
    Kozin SV; Boucher Y; Hicklin DJ; Bohlen P; Jain RK; Suit HD
    Cancer Res; 2001 Jan; 61(1):39-44. PubMed ID: 11196192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
    Schuuring J; Bussink J; Bernsen HJ; Peeters W; van Der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):529-34. PubMed ID: 15667976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
    Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
    Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib and radiation: a promising combination in colorectal cancer.
    Suen AW; Galoforo S; Marples B; McGonagle M; Downing L; Martinez AA; Robertson JM; Wilson GD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):213-20. PubMed ID: 20708486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model.
    Norum OJ; Bruland ØS; Gorunova L; Berg K
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):878-85. PubMed ID: 19665318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
    J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
    Dearling JL; Qureshi U; Begent RH; Pedley RB
    Clin Cancer Res; 2007 Mar; 13(6):1903-10. PubMed ID: 17363547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor.
    Schuck A; Poremba C; Lanvers C; Könemann S; Schleifer T; Wai D; Horn K; Hesselmann S; Braun Y; Frodermann B; Schäfer KL; Diallo RI; Rübe CE; Rübe C; Dockhorn-Dworniczak B; Willich N
    Strahlenther Onkol; 2002 Dec; 178(12):701-8. PubMed ID: 12491058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA; Krause M; Zyromska A; Lambin P; Baumann M; Wouters BG
    Radiother Oncol; 2007 Jan; 82(1):96-104. PubMed ID: 17161482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation.
    Zips D; Krause M; Hessel F; Westphal J; Brüchner K; Eicheler W; Dörfler A; Grenman R; Petersen C; Haberey M; Baumann M
    Anticancer Res; 2003; 23(5A):3869-76. PubMed ID: 14666690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.
    Krause M; Wohlfarth J; Georgi B; Pimentel N; Dorner D; Zips D; Eicheler W; Hessel F; Short SC; Joiner MC; Baumann M
    Int J Radiat Biol; 2005 Oct; 81(10):751-8. PubMed ID: 16449082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
    Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
    Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
    Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.